Total planned funding: $735,276,982
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $157,315,761 |
Tanzania | $95,405,273 |
Uganda | $72,870,270 |
Kenya | $63,307,748 |
Rwanda | $43,018,013 |
Mozambique | $27,560,739 |
Lesotho | $26,628,811 |
Democratic Republic of the Congo | $26,331,525 |
South Africa | $25,779,261 |
Eswatini | $22,720,414 |
Nigeria | $19,175,573 |
Côte d'Ivoire | $18,345,355 |
Malawi | $18,266,187 |
Ethiopia | $18,116,242 |
Botswana | $12,254,064 |
Central Asia Region | $12,209,048 |
Central America Region | $8,681,742 |
Zimbabwe | $8,266,297 |
India | $7,400,000 |
Ghana | $7,392,773 |
Namibia | $7,013,036 |
Cameroon | $6,000,000 |
Asia Regional Program | $5,453,520 |
South Sudan | $5,312,178 |
Burma | $3,975,000 |
Haiti | $3,175,000 |
Ukraine | $2,800,000 |
Caribbean Region | $1,858,861 |
Burundi | $1,682,288 |
Vietnam | $1,635,150 |
Cambodia | $1,450,313 |
Indonesia | $1,298,000 |
Dominican Republic | $1,118,131 |
Guyana | $1,010,800 |
Papua New Guinea | $449,609 |
Program Areas
Care | $249,582,994 |
Treatment | $183,261,169 |
Prevention | $144,816,315 |
Governance and Systems | $118,088,056 |
Testing | $41,638,048 |
Budget Codes
HTXS: Treatment: Adult Treatment | $154,107,699 |
HKID: Care: Orphans and Vulnerable Children | $128,110,018 |
HBHC: Care: Adult Care and Support | $63,211,456 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $54,341,495 |
HVSI: Strategic Information | $48,772,783 |
OHSS: Health Systems Strengthening | $47,975,948 |
HVCT: Testing: HIV Testing and Counseling | $41,638,048 |
HVTB: Care: TB/HIV | $40,926,904 |
HVOP: Sexual Prevention: Other Sexual Prevention | $37,962,116 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $33,103,418 |
PDTX: Treatment: Pediatric Treatment | $24,148,125 |
HLAB: Laboratory Infrastructure | $21,339,325 |
PDCS: Care: Pediatric Care and Support | $17,334,616 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,489,463 |
HMIN: Biomedical Prevention: Injection Safety | $5,684,777 |
HTXD: Treatment: ARV Drugs | $5,005,345 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,807,176 |
HMBL: Biomedical Prevention: Blood Safety | $2,427,870 |